Thomas White International Ltd. Buys 17,733 Shares of Alphabet Inc. (NASDAQ:GOOG)

Thomas White International Ltd. raised its stake in shares of Alphabet Inc. (NASDAQ:GOOG – Get Rating) by 1,896.6% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 18,668 shares of the information services provider’s stock after acquiring an additional 17,733 shares during the quarter. Thomas White International Ltd.’s holdings in Alphabet were worth $1,795,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. OLD Second National Bank of Aurora raised its holdings in shares of Alphabet by 1,900.0% in the third quarter. OLD Second National Bank of Aurora now owns 260 shares of the information services provider’s stock valued at $25,000 after buying an additional 247 shares during the last quarter. Westchester Capital Management Inc. raised its holdings in shares of Alphabet by 1,900.0% in the third quarter. Westchester Capital Management Inc. now owns 260 shares of the information services provider’s stock valued at $25,000 after buying an additional 247 shares during the last quarter. Carolina Wealth Advisors LLC raised its holdings in shares of Alphabet by 1,900.0% in the third quarter. Carolina Wealth Advisors LLC now owns 300 shares of the information services provider’s stock valued at $29,000 after buying an additional 285 shares during the last quarter. Saban Cheryl raised its holdings in shares of Alphabet by 1,900.0% in the third quarter. Saban Cheryl now owns 200 shares of the information services provider’s stock valued at $29,000 after buying an additional 190 shares during the last quarter. Finally, NewSquare Capital LLC raised its holdings in shares of Alphabet by 1,900.0% in the third quarter. NewSquare Capital LLC now owns 320 shares of the information services provider’s stock valued at $31,000 after buying an additional 304 shares during the last quarter. 28.69% of the stock is owned by institutional investors.

Insider Buying and Selling at Alphabet

In other Alphabet news, CAO Amie Thuener O’toole sold 637 shares of the business’s stock in a transaction that occurred on Wednesday, March 1st. The stock was sold at an average price of $90.15, for a total value of $57,425.55. Following the sale, the chief accounting officer now owns 25,442 shares in the company, valued at approximately $2,293,596.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other Alphabet news, CAO Amie Thuener O’toole sold 637 shares of the business’s stock in a transaction that occurred on Wednesday, March 1st. The stock was sold at an average price of $90.15, for a total value of $57,425.55. Following the sale, the chief accounting officer now owns 25,442 shares in the company, valued at approximately $2,293,596.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Ann Mather sold 380 shares of the business’s stock in a transaction that occurred on Tuesday, December 27th. The shares were sold at an average price of $89.24, for a total value of $33,911.20. Following the completion of the sale, the director now owns 11,300 shares in the company, valued at approximately $1,008,412. The disclosure for this sale can be found here. In the last quarter, insiders have sold 36,745 shares of company stock worth $3,424,078. Corporate insiders own 12.99% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on GOOG. Credit Suisse Group set a $136.00 price objective on Alphabet in a research report on Friday, February 3rd. Piper Sandler lowered their price objective on Alphabet from $122.00 to $120.00 and set an “overweight” rating for the company in a research report on Friday, February 3rd. Roth Capital reiterated a “buy” rating on shares of Alphabet in a research report on Friday, February 3rd. Oppenheimer lifted their price objective on Alphabet from $130.00 to $155.00 and gave the stock an “outperform” rating in a research report on Friday, February 3rd. Finally, Royal Bank of Canada set a $130.00 price objective on Alphabet in a research report on Friday, February 3rd. One analyst has rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $137.13.

Alphabet Price Performance

Shares of GOOG opened at $94.25 on Wednesday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.34 and a current ratio of 2.38. The stock has a 50 day simple moving average of $94.96 and a 200 day simple moving average of $96.85. Alphabet Inc. has a 52-week low of $83.45 and a 52-week high of $144.16. The firm has a market capitalization of $1.21 trillion, a PE ratio of 20.71, a P/E/G ratio of 1.26 and a beta of 1.09.

Alphabet (NASDAQ:GOOG – Get Rating) last issued its quarterly earnings data on Thursday, February 2nd. The information services provider reported $1.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.14 by ($0.09). Alphabet had a net margin of 21.20% and a return on equity of 23.54%. The business had revenue of $76.05 billion during the quarter, compared to analyst estimates of $76.49 billion. During the same quarter in the prior year, the firm posted $1.53 earnings per share. Alphabet’s revenue for the quarter was up 1.0% compared to the same quarter last year. Sell-side analysts predict that Alphabet Inc. will post 5.12 EPS for the current fiscal year.

Alphabet Profile

(Get Rating)

Alphabet, Inc engages in the business of delivering online advertising, cloud-based solutions that provide enterprise customers with infrastructure and platform services, the provision of communication and collaboration tools, and sales of other products and services such as apps and in-app purchases, hardware, and subscription-based products.